About Mugass Pharma Private Limited
Data last updated:
Mugass Pharma Private Limited is a private limited company based in Hathras, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 14 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2018PTC110281.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saurabh Verma and Sonam Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 4 1st Floor Seth P.C. Bagla Degree College Society Shopping Block, Hathras, Uttar Pradesh, India – 204101.
As per the financials filed for FY 2025, the company reported a revenue of ₹55,790, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹98 (net margin -0.2%) and EBITDA of -₹98 (EBITDA margin -0.2%).
For more details, the company can be reached via its website mugasspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressShop No. 4 1st Floor Seth P.C. Bagla Degree College Society Shopping Block, Hathras, Uttar Pradesh, India – 204101
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Mugass Pharma Private Limited FY 2025 filings available
Mugass Pharma Private Limited reported revenue of ₹55,790 (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mugass Pharma Private Limited
Revenue rose 3% in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mugass Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹98 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹98 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mugass Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mugass Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Mugass Pharma Private Limited
Mugass Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Verma | Director | 14 Nov 2018 | 7 Years 10 Months | Current |
| Sonam Verma | Director | 14 Nov 2018 | 7 Years 10 Months | Current |
Ownership and Shareholding of Mugass Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mugass Pharma Private Limited
Mugass Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Mugass Pharma Private Limited
Employment history and EPFO contributions of people linked to Mugass Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mugass Pharma Private Limited
Mugass Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Harsh Singhania ceased to be Director on 01 Feb 2025.
Credit Ratings, Litigation & Regulatory Alerts for Mugass Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mugass Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mugass Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mugass Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mugass Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mugass Pharma Private Limited
Mugass Pharma is an active private limited company based in Hathras, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 14 November 2018 (8+ years old) and is registered under CIN U74999UP2018PTC110281.
Mugass Pharma reported revenue of ₹55,790 for FY 2025 (up 3% YoY).
Mugass Pharma has 2 current directors:
- Saurabh Verma - Director
- Sonam Verma - Director
Mugass Pharma reported a net loss of ₹98 (net margin -0.2%) and EBITDA of -₹98 (EBITDA margin -0.2%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Mugass Pharma is U74999UP2018PTC110281. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mugass Pharma was incorporated on 14 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Harsh Singhania ceased to be Director on 01 Feb 2025. Saurabh Verma was appointed as Director on 14 Nov 2018. Sonam Verma was appointed as Director on 14 Nov 2018.
Mugass Pharma can be reached through the website mugasspharma.com. Its registered office is in Hathras, Uttar Pradesh, India.
The registered office of Mugass Pharma is at Shop No. 4 1st Floor Seth P.C. Bagla Degree College Society Shopping Block, Hathras, Uttar Pradesh, India – 204101.
Mugass Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.